Pre-treated anti-PD-1 refractory Merkel cell carcinoma successfully treated with the combination of PD-1/PD-L1 axis inhibitors and TVEC: a report of two cases.
Publication
, Journal Article
Knackstedt, R; Sussman, TA; McCahon, L; Song, J-M; Funchain, P; Gastman, B
Published in: Ann Oncol
August 1, 2019
Duke Scholars
Altmetric Attention Stats
Dimensions Citation Stats
Published In
Ann Oncol
DOI
EISSN
1569-8041
Publication Date
August 1, 2019
Volume
30
Issue
8
Start / End Page
1399 / 1400
Location
England
Related Subject Headings
- Treatment Outcome
- Skin Neoplasms
- Programmed Cell Death 1 Receptor
- Positron-Emission Tomography
- Oncology & Carcinogenesis
- Male
- Lymphatic Metastasis
- Humans
- Herpesvirus 1, Human
- Drug Synergism
Citation
APA
Chicago
ICMJE
MLA
NLM
Knackstedt, R., Sussman, T. A., McCahon, L., Song, J.-M., Funchain, P., & Gastman, B. (2019). Pre-treated anti-PD-1 refractory Merkel cell carcinoma successfully treated with the combination of PD-1/PD-L1 axis inhibitors and TVEC: a report of two cases. Ann Oncol, 30(8), 1399–1400. https://doi.org/10.1093/annonc/mdz187
Knackstedt, R., T. A. Sussman, L. McCahon, J. -. M. Song, P. Funchain, and B. Gastman. “Pre-treated anti-PD-1 refractory Merkel cell carcinoma successfully treated with the combination of PD-1/PD-L1 axis inhibitors and TVEC: a report of two cases.” Ann Oncol 30, no. 8 (August 1, 2019): 1399–1400. https://doi.org/10.1093/annonc/mdz187.
Knackstedt R, Sussman TA, McCahon L, Song J-M, Funchain P, Gastman B. Pre-treated anti-PD-1 refractory Merkel cell carcinoma successfully treated with the combination of PD-1/PD-L1 axis inhibitors and TVEC: a report of two cases. Ann Oncol. 2019 Aug 1;30(8):1399–400.
Knackstedt, R., et al. “Pre-treated anti-PD-1 refractory Merkel cell carcinoma successfully treated with the combination of PD-1/PD-L1 axis inhibitors and TVEC: a report of two cases.” Ann Oncol, vol. 30, no. 8, Aug. 2019, pp. 1399–400. Pubmed, doi:10.1093/annonc/mdz187.
Knackstedt R, Sussman TA, McCahon L, Song J-M, Funchain P, Gastman B. Pre-treated anti-PD-1 refractory Merkel cell carcinoma successfully treated with the combination of PD-1/PD-L1 axis inhibitors and TVEC: a report of two cases. Ann Oncol. 2019 Aug 1;30(8):1399–1400.
Published In
Ann Oncol
DOI
EISSN
1569-8041
Publication Date
August 1, 2019
Volume
30
Issue
8
Start / End Page
1399 / 1400
Location
England
Related Subject Headings
- Treatment Outcome
- Skin Neoplasms
- Programmed Cell Death 1 Receptor
- Positron-Emission Tomography
- Oncology & Carcinogenesis
- Male
- Lymphatic Metastasis
- Humans
- Herpesvirus 1, Human
- Drug Synergism